Table 1 General and clinical data of HCC patients and controls groups
HCC patients (%) n = 119 | Controls (%) n = 103 | |
|---|---|---|
Age (Mean ± SD) | 63.45 ± 12.59 | 56 ± 10.82 |
Sex ratio (M:F) | 1.53 (72/47) | 1.29 (58/45) |
Ongoing co-infection HBV + HCV | 4 (3.4) | 0 |
Chronic hepatitis B (HBsAg+) | 12 (10.1) | 0 |
Chronic hepatitis C (anti-HCV+) | 76 (63.9) | 0 |
Resolved Hepatitis B (HBsAg-/anti-HBc+) | 40 (33.6) | 30 (29.1) |
No history of hepatitis B or C | 15 (12.6) | 73 (70.9) |
Type 2 Diabetes | 7 (5.9) | 1 (0.9) |